These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 6971708)
41. Immunocytochemical method for the detection of terminal deoxynucleotidyl transferase in acute leukemia. Ho AD; Helmstädter V; Hunstein W Klin Wochenschr; 1982 May; 60(9):451-5. PubMed ID: 7045509 [TBL] [Abstract][Full Text] [Related]
42. Terminal deoxynucleotidyl transferase activity in neoplastic and nonneoplastic hematopoietic cells. Bearman RM; Winberg CD; Maslow WC; Racklin B; Carlson F; Nathwani BN; Kim H; Diamond LW; Fallis B; Rappaport H Am J Clin Pathol; 1981 Jun; 75(6):794-802. PubMed ID: 7020399 [TBL] [Abstract][Full Text] [Related]
43. TdT activity in bone-marrow serum in patients with leukemia. Sasaki R; Takaku F; Dan S; Bollum FJ N Engl J Med; 1981 Apr; 304(18):1108. PubMed ID: 7207575 [No Abstract] [Full Text] [Related]
44. Terminal deoxynucleotidyl transferase activity in thymus biopsies of immunodeficient patients. Jones JF; Meyskens FL; Henley MJ; Schmalstieg FC; Hong R Thymus; 1982 Sep; 4(5):287-97. PubMed ID: 7179406 [No Abstract] [Full Text] [Related]
45. Induction of terminal deoxynucleotidyl transferase and Lyt antigens with thymosin: identification of multiple subsets of prothymocytes in mouse bone marrow and spleen. Goldschneider I; Ahmed A; Bollum FJ; Goldstein AL Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2469-73. PubMed ID: 6972536 [TBL] [Abstract][Full Text] [Related]
47. Terminal deoxynucleotidyl transferase in the blastic phase of chronic myelogenous leukemia: an indicator of response to vincristine and prednisone therapy. Tanaka M; Kaneda T; Hirota Y; Yoshida S; Kitajima K Am J Hematol; 1980; 9(3):287-93. PubMed ID: 6940442 [TBL] [Abstract][Full Text] [Related]
48. Terminal deoxynucleotidyl transferase expression in a Thy-l alloantigen variant lymphoma cell line. Bumol TF; Retzel EF; Douglas SD; Basch RS; Buxbaum JN; Faras AJ Immunology; 1980 Dec; 41(4):799-806. PubMed ID: 7461712 [TBL] [Abstract][Full Text] [Related]
50. The origin of multiple forms of human and calf terminal deoxynucleotidyl transferase: a model for in vivo processing. Deibel MR; Riley LK; Coleman MS Isozymes Curr Top Biol Med Res; 1983; 7():297-315. PubMed ID: 6411650 [No Abstract] [Full Text] [Related]
51. Modulation of terminal deoxynucleotidyl transferase activity by thymosin. Hu SK; Low TL; Goldstein AL Mol Cell Biochem; 1981 Dec; 41():49-58. PubMed ID: 7329413 [TBL] [Abstract][Full Text] [Related]
52. Double fluorochrome analysis of human bone marrow lymphoid cells: studies with terminal transferase and anti-T-cell monoclonal antibodies. Neudorf SM; Le Bien TW; Bollum F; Kersey JH Exp Hematol; 1984 Jan; 12(1):69-73. PubMed ID: 6607843 [TBL] [Abstract][Full Text] [Related]
56. Intracellular distribution of terminal deoxynucleotidyl transferase in rat bone marrow and thymus. Gregoire KE; Goldschneider I; Barton RW; Bollum FJ Proc Natl Acad Sci U S A; 1977 Sep; 74(9):3993-6. PubMed ID: 333454 [TBL] [Abstract][Full Text] [Related]
57. Clinical significance of TdT, cell surface markers and CFU-C in 297 patients with hematopoietic neoplasias. Mertelsmann R; Koziner B; Filippa DA; Grossbard E; Incefy G; Moore MA; Clarkson BD Haematol Blood Transfus; 1979; 23():131-8. PubMed ID: 317470 [No Abstract] [Full Text] [Related]
58. Hybrids between myeloma cells and thymocytes - and attempt to approach the biological function of terminal transferase. Transy C; Rouget P Adv Exp Med Biol; 1982; 145():207-19. PubMed ID: 6981291 [No Abstract] [Full Text] [Related]
59. Distribution of terminal deoxynucleotidyl transferase activity between peaks I and II in host and donor thymic cells of bone-marrow-restored mice after X-irradiation. Daculsi R; Astier T; Legrand E; Duplan JF Int J Radiat Biol Relat Stud Phys Chem Med; 1983 Nov; 44(5):455-61. PubMed ID: 6358078 [TBL] [Abstract][Full Text] [Related]